大象传媒

Skip to main content

大象传媒 My Chart

March 28, 2025

Hemofil M & Recominate discontinuing mid 2026

Takeda stated it would continue to supply both medications to current patients until inventory is depleted or expires in mid-2026.听 If you rely on one of these products, please reach out to your specialty pharmacy with any questions.听 You should have received a letter in the mail also.听 More information can be found at: https://www.bleeding.org/news/breaking-news-takeda-announces-discontinuation-of-two-hemophilia-treatments.

 

More News